Personalized Responses to Dietary Composition Trial 3

NCT04735835 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250000

Last updated 2025-04-16

No results posted yet for this study

Summary

The PREDICT 3 study will build on previous research in over 2,000 individuals to further refine machine learning models that predict individual responses to foods, with the aim of advancing precision nutrition science and individualized dietary advice. The study incorporates both standardized and controlled dietary intervention, for the purpose of testing postprandial responses to specific mixed meals, in addition to a free-living period with a dietary record for measuring responses to a large variety of meals consumed in a realistic context, where the role of external factors (e.g. exercise, sleep, time of day) on postprandial responses may be determined. For the first time this PREDICT study is built on top of a commercial product which will allow access to a much larger group of participants who are already collecting large amounts of data through digital and biochemical devices that can contribute to science.

Conditions

  • Diabetes
  • Heart Diseases
  • Diet Habit
  • Diet Modification
  • Healthy
  • Obesity
  • Metabolism
  • Microbial Colonization

Interventions

OTHER

Dietary Intervention

To carry out a dietary intervention using standardized test meals, where the participant's postprandial response to the meal is measured and is used to predict their postprandial responses to other foods, along with input variables including metabolic profile, anthropometry, sleep and exercise.

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER
  • Stanford University

    collaborator OTHER
  • Harvard School of Public Health (HSPH)

    collaborator OTHER
  • Zoe Global Limited

    lead OTHER

Principal Investigators

  • Tim Spector, PhD · Zoe Global Limited

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-20
Primary Completion
2030-01-01
Completion
2030-01-01

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04735835 on ClinicalTrials.gov